SUNREST — Sunrest Lifescience Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹200.40m
- IN₹356.71m
- IN₹334.13m
- 42
- 76
- 41
- 55
Annual cashflow statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.24 | 10.5 | 27.4 | 5.93 | 26.2 |
| Depreciation | |||||
| Non-Cash Items | 0 | -0.224 | 0 | — | 0.041 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.13 | -15.4 | -17.2 | -155 | 1.99 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.53 | -4.49 | 11.5 | -148 | 29.2 |
| Capital Expenditures | -1.62 | -4.67 | -0.142 | -0.071 | -13.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 1.1 | -0.165 | 0 | 2.27 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -1.62 | -3.56 | -0.307 | -0.071 | -11.4 |
| Financing Cash Flow Items | -0.075 | -0.108 | -0.591 | -2.18 | -3.04 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.381 | 9.12 | -11.5 | 146 | -3.27 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.296 | 1.07 | -0.301 | -1.6 | 14.5 |